Medications

A potential antiviral for SARS and SARS-like coronaviruses

Both SARS-CoV-1, the virus that caused the 2003 outbreak of Severe Acute Respiratory Syndrome (SARS), and SARS-CoV-2, which causes COVID-19, originate from a group of betacoronaviruses known as "subgroup 2b." Coronaviruses ...

Diseases, Conditions, Syndromes

Researchers estimate the true prevalence of COVID-19 taste loss

Reports of taste loss, a symptom of COVID-19, have been on the rise over the last two years. The taste dysfunction comes in different forms, including ageusia (total taste loss), hypogeusia (partial taste loss), and dysgeusia ...

Diseases, Conditions, Syndromes

Researchers develop molecular traps to target SARS-CoV-2

A research team led by scientists at UC Riverside and UCLA has engineered novel nanoparticles to serve as "molecular traps" to target SARS-CoV-2, the virus that spreads COVID-19. The traps bind to SARS-CoV-2 and prevent it ...

Genetics

New hope for people living with a genetic cause of autism

Fragile X syndrome, or FXS, a leading genetic cause of autism, affects around one in 4,000 males and one in 6,000 females. Its symptoms include increased anxiety, intellectual disability, repetitive behaviors, social communication ...

Inflammatory disorders

Melatonin exacerbates asthma

Asthma sufferers generally find their condition gets worse at night. Now, a research group may understand why. Melatonin, a sleep hormone that is sometimes prescribed to treat insomnia, exasperates the constriction of the ...

page 8 from 25